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Radiofrequency-based treatment in therapy-related clinical practice – A 
narrative review. Part II: Chronic conditions 
 
ABSTRACT 
Background: Radiofrequency (RF)-based electrophysical agents (EPAs) have been 
employed in therapy-related clinical practice for several decades. They are used to reduce 
pain and inflammation and promote tissue healing. Although deemed less popular in current 
therapy practice, surveys suggest that some of these EPAs are still used reasonably widely. 
Objective: To review the evidence for the use of non-invasive low frequency RFs (30 kHz–
30 MHz) for treating chronic therapy-related clinical conditions. 
Major findings: All relevant peer-reviewed clinical studies published in English, concerning 
low frequency RFs were sought. Identified literature was stratified as ‘acute’ and ‘chronic’ 
based on their clinical area. The studies on chronic conditions were reviewed for this paper 
and analysed to assess the volume and scope of current evidence. Out of 120 studies 
identified, 90 related to chronic conditions. The majority of them (82 studies) employed 
Shortwave Therapy (SWT) in continuous (CSWT) or pulsed (PSWT) modes. Only eight 
studies employed frequencies other than shortwave. Overall 67 studies investigated 
conditions relating to ‘pain and inflammation’, 16 to ‘tissue healing’ and seven studies to 
other less reported conditions. 
Conclusions: Evidence favouring and against RF-based EPAs is available. There is moderate 
evidence favouring the use of SWT (mainly PSWT) in knee osteoarthritis. Some evidence 
also exists for CSWT in chronic low back pain and PSWT for treating chronic wounds. 
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Evidence for other conditions is insufficient and conflicting. A general lack of research 
emphasis in the non-shortwave RF band is evident. Further and wider research in this area is 
necessary. 
KEY WORDS 
Chronic conditions; Clinical effects; Electrophysical agents; Non-invasive; Radiofrequency. 
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INTRODUCTION 
Therapeutic use of electrophysical energy has been well-established since the past century, 
making the treatment using electrophysical agents (EPAs) a key area in the realm of 
physiotherapy.
1,2
 Devices that employ radiofrequency electromagnetic field (RFEMF or 
simply RF) are a major component of EPAs, the use of which has been reported since the 
early decades of last century.
3
 
The therapeutic effects of RF are mainly linked to their effects on pain relief and tissue 
repair.
4,5
 These effects may be achieved either through thermal or through non-thermal 
mechanisms, which are essentially dose dependent.
5,6
 At higher doses the cardinal effects of 
RF are heat-related physiological changes triggered by a rise in the tissue temperature.
7-10
 At 
substantially lower doses of RF, a discernible rise in tissue temperature is not achieved,
7,8
 but 
rather the absorption of RF energy in tissues instigate a modulation in cellular activity and 
alter membrane transport.
5
 Although less well understood compared to the thermal effects, 
the non-thermal effects of RF and the mechanisms underpinning those effects have become 
more established in the recent years.
11-13
 
Even though a key component among the EPAs, RF devices have become less popular lately. 
The RF frequency ranges presently used in therapy practice have become restricted largely to 
30 kHz–30,000 kHz (30 MHz).14 The drop in popularity of RF-based EPAs has been 
reciprocated by the evolution and increased popularity of other forms of EPAs such as 
ultrasound, laser, transcutaneous electrical nerve stimulation (TENS) and interferential 
therapy (IFT).
15-17
 However, it may be argued that this swing towards other non-RF therapies 
may have been a fashionable shift rather than based on evidence per se. The fall in the use of 
RF-based EPAs is evidenced by the findings from recent surveys and reviews.
14,18
 That 
having been said, a recent audit in the UK has reported that RF-based EPAs such as the 
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pulsed shortwave therapy (PSWT) is still used among about 11% of outpatient clinics in the 
UK.
17
 
In part I
19
 of this review published by the same authors, the evidence for RF-based EPAs 
within the frequency range of 30 kHz–30 MHz used in the treatment of acute therapy-related 
clinical conditions was presented. The objective of this paper (part II) is to review similar RF-
based studies published to date on chronic conditions. In the current literature, apart from the 
reviews on varying specific conditions and specific RF energy types,
6,20-25
 no reviews 
covering the whole RF literature on chronic conditions could be identified. Hence, to our 
knowledge this is the first such attempt. 
In part I,
19
 although beyond the primary remit of the review itself, relevant RF studies 
performed on laboratory animals were also covered in order to illustrate some key issues. 
However, unlike in acute conditions, the authors identified only one animal study
26
 that 
evaluated the effects of RF-based therapy that was directly relevant to chronic clinical 
conditions. 
Vanharanta
26
 investigated the effect of continuous shortwave therapy (CSWT) on the joint 
mobility and radiographic changes during the development of osteoarthritis (OA) of the knee 
joint. The authors developed an experimental model of OA knee by periodically 
immobilising the knee joints of rabbits. They were then treated with CSWT (55 sessions in 11 
weeks, 5 minutes per session) and compared with an identical group of non-treated control 
rabbits. The groups did not show any significant difference between them post treatment, in 
terms of joint mobility or radiological changes. A lack of further animal studies relevant to 
chronic conditions made it difficult to draw a definite comparison with human studies. 
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METHODS 
A detailed account of the methods adopted for this review has been reported previously in 
part I
19
 of this review. While the first part presented the overall search results and a review of 
the studies (published in English) on RF-based EPAs (30 kHz–30 MHz) conducted on acute 
conditions, part II aimed to review the identified studies that were conducted on chronic 
conditions. As detailed in part I,
19
 the authors adopted an all-inclusive methodological 
approach for the purpose of this review; several examples of which are available in the 
literature.
27-30
 This approach is dissimilar to that of a systematic review and does not exclude 
studies based on their methodological design and/or quality as would be the norm in a 
systematic review. 
The identified studies were stratified on the basis of the frequency of RF used (shortwave, 
non-shortwave), the study design (clinical trial, cohort study, case study), and their clinical 
application category [pain and inflammation, tissue healing, others (all other less reported 
conditions, e.g. – postoperative stiffness of joints)]. For the purpose of this review ‘chronic’ 
is considered as conditions older than six weeks. The authors understand that it is problematic 
to divide studies in to distinct acute and chronic categories as conditions may overlap to a 
varied extent. However, based on available examples
31,32
 the terms ‘acute’ and ‘chronic’ are 
not explicitly defined in the existing literature and any duration used for classifications have 
been based merely on personal opinion or anecdotal evidence.
33
 
The studies employing devices generating RF between 10–30 MHz were considered as 
shortwave studies, and those employing RF between 30 kHz–10 MHz as non-shortwave 
studies. The methodological quality of the studies was screened using the Cochrane risk of 
bias assessment tool
34
 where appropriate and scored based on the checklist proposed by 
Downs and Black
35
 for randomised and non-randomised studies. 
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The Downs and Black checklist is a valid tool
36
 containing 27 items concerning the quality of 
reporting, validity, bias and statistical power of the studies (maximum score of 32; higher the 
score better the quality). Over the years, several authors have used modified versions of this 
checklist, mainly by simplifying the ‘item 27’ (originally scored 0–5) that concerns statistical 
power.
37,38
 A similar modified version, scoring item 27 as either ‘zero’ (insufficient power) or 
‘one’ (sufficient power) was used in this review. Hence, the maximum score that could be 
achieved by a study was 28. 
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RESULTS 
The flow of studies through the review is given in Figure 1. Out of the 120 studies that were 
originally identified
19
 on the use of RF-based treatment in therapy practice, a total of 90 
(75%) studies investigated chronic conditions. Out of 90, there were 82 (91%) shortwave 
studies and eight (9%) non-shortwave studies. Sixty-seven studies (74%) were conducted on 
conditions relating to pain and inflammation and 16 (18%) on conditions relating to tissue 
healing. A further seven studies (8%) were classed as ‘others’ and related to a mixture of 
conditions that were reported relatively rarely (e.g. – postoperative stiffness of joints) (Figure 
2). 
However, as identified, the authors recognise that it is challenging to classify studies into 
such distinct clinical categories stated above, given that they may overlap to a varied extent. 
Clearly there was potential overlap between studies (although more so for the acute studies) 
that considered pain and inflammation and that considered tissue healing. For the purpose of 
this review, the allocation of a particular paper into a group was based on the primary 
outcome(s) as identified by their authors. The full texts were available for all the studies 
discussed here except for three.
39-41
 
**Insert Figure 1 here** 
**Insert Figure 2 here** 
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DISCUSSION OF RESULTS 
All 90 studies that investigated the effects of RF on chronic clinical conditions are considered 
in detail in the following sections. The types of RF used, key characteristics including dose 
parameters (where reported) and the Downs and Black scores are given as tables in their 
respective sections. 
NON-SHORTWAVE STUDIES 
Eight studies employed RF between the frequencies 30 kHz–10 MHz for the management of 
chronic clinical conditions. Five of these studies were clinical trials;
42-46
 one cohort study
47
 
and the remaining two were case studies.
48,49
 All eight studies reported conditions giving rise 
to pain and inflammation. Four were on OA of the knee joint,
44-47
 and one each on shoulder 
pain,
49
 temporo-mandibular joint (TMJ) pain and dysfunction,
42
 tendinopathy
43
 and other 
chronic pain conditions.
48
 The RF employed ranged from 250–500 kHz across all studies, 
except that by Takahashi and colleagues
47
 and the study by Nelson and colleagues
46
 where 
frequencies of 6,000–8,000 kHz (6–8 MHz) were used. 
In one of the three randomised controlled trials (RCT) on OA knee, Nelson and colleagues
46
 
reported a three-fold improvement in VAS pain scores of 15 participants when treated with 
an active 6.8 MHz pulsed electromagnetic field (PEMF) device [80 (±9) sessions in 42 days, 
15 minutes per session] compared with a placebo-treated group of 19 participants. Pain was 
the only outcome measured in this study, with no follow-up measurements beyond the 
immediate post treatment phase. 
Similarly, Taverner and colleagues
45
 used 480 kHz transcutaneous pulsed radiofrequency 
(TPRF) therapy (single session for 10 minutes) against a placebo-TPRF on 52 participants (in 
two groups: active and placebo) awaiting total knee replacement (TKR). The study reported a 
10 
 
statistically significant reduction in the pain (VAS) scores of active group participants at one 
and four weeks post treatment compared to the placebo group. 
In another clinical trial, Alcidi and colleagues
44
 tested 500 kHz RF (five sessions in five days, 
20 minutes per session) against TENS (50 Hz, 0.5-millisecond square waves for 20 minutes 
per session for five days) in 40 patients with OA knee (two groups of 20 each). The RF 
therapy induced a statistically significant and longer lasting reduction in pain compared to the 
TENS. However, while a 20-minute treatment is appropriate for RF, it may be too short for 
TENS to be effective.
2
 Also, pain relief with TENS is shown to be prominent during the 
treatment as opposed to post-treatment.
50
 
All three RCTs were small with very short assessment periods and a limited number of 
outcome measures. None of them employed a true control group, nor did they account for 
confounding factors such as the use of medication. 
Takahashi and colleagues
47
 conducted a pilot study on 12 patients presenting with OA knee 
using an 8 MHz RF applicator (three sessions in three weeks, 20 minutes per session). They 
demonstrated that 8 MHz RF can be used safely to induce hyperthermia inside the knee joints 
and obtain significant pain relief. The temperature inside the joint was recorded using an 
invasive metallic thermocouple that remained in situ for the duration of treatment. This could 
potentially have caused a direct heating of the thermocouple by the RF. It was not possible to 
determine from the paper whether the researchers had attempted to mediate this effect. 
In a mixed case series by Balogh,
48
 TPRF therapy was applied to four patients who had 
suffered lumbar intervertebral disc and other injuries, using conventional TENS electrodes 
and a 500 kHz RF generator (10 minutes at 1–5 week intervals). Three out of the four patients 
treated reported significant improvement in self-reported pain and function. However, the 
treatment protocols were variable for each patient. In a similar study, Taverner and 
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colleagues
49
 used RF at 480 kHz (single session of TPRF therapy for up to 12 minutes) to 
treat a cohort of 13 patients suffering from shoulder pain (15 shoulder joints). Two-thirds of 
their participants reported pain relief over three months. 
Al-Badawi and colleagues
42
 achieved a significant reduction in TMJ pain and improvement 
in mandibular range of movement (ROM) in a double-blinded RCT with 40 participants (two 
groups of 20 each). The subjects were exposed to either 250 kHz pulsed RF (PRF) or 
placebo-PRF (six sessions in two weeks, 90 seconds per session), and then followed up for 
two weeks. The authors concluded that the overall beneficial effect of PRF on TMJ reported 
pain is a combination of a placebo and true therapeutic effects. This was difficult to be 
ascertained from these results though, as a true control group was not employed. 
In a further study by Costantino and colleagues,
43
 the immediate clinical effects on pain 
obtained by 448 kHz Capacitive Resistive Monopolar RF (CRMRF) therapy were found to be 
significant yet equivalent to those obtained by cryoultrasound therapy and laser CO2 therapy. 
Forty-five athletes suffering from extensor tendinopathy (Achilles, patellar or elbow) were 
treated in three equal groups, each receiving 12 sessions of one of the three modalities (RF 
was given for 30 minutes, laser for 15 minutes and cryoultrasound for 20 minutes). 
In summary, only a limited number of clinical studies have been published in the non-
shortwave RF category. They suggest that RF energy below the frequency of 10 MHz might 
deliver appreciable therapeutic effects. However, these results should only be considered 
against their overall methodological quality, several of which were problematic. The paucity 
of controlled clinical studies and the poor overall methodological quality imply the need for 
substantially more research in this area. In addition, because of the varied nature of the 
frequency and dosage parameters used by their authors, any potential range of ideal doses 
could not be identified. The rationale for frequency and dose selection was also not reported. 
12 
 
**Insert Table I here** 
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SHORTWAVE STUDIES 
The authors identified 82 clinical studies relating to chronic conditions that employed RF 
within the shortwave frequency range of 10–30 MHz. All studies used devices delivering 
energy at the base shortwave frequency of 27.12 MHz either in the continuous (CSWT) or in 
the pulsed (PSWT) mode. Overall, 59 studies investigated conditions giving rise to pain and 
inflammation, 16 studies investigated tissue healing and the remaining seven studies 
examined other less reported conditions such as postoperative stiffness of joints. 
STUDIES ON PAIN AND INFLAMMATION 
With 59 studies, this is the largest group in terms of the number of studies published. Almost 
half of them (28 studies) reported the effects of RF-based therapy on arthritis, predominantly 
OA of the knee joint.
51-78
 Twenty-seven of these studies were clinical trials and one cohort 
experimental study
52
 on the effect of CSWT on radio-sodium clearance from the knee joint. 
A further eight clinical trials
41,79-85
 and one cohort study
86
 investigated chronic low back pain 
(LBP), and one clinical trial
87
 and five case studies
88-92
 investigated various pelvic pain 
(gynaecological) conditions. 
In addition, three clinical trials
93-95
 were identified on chronic neck disorders, one clinical 
trial
96
 and one case study
97
 each on plantar fasciitis; and one clinical trial
98
 and one case 
study
99
 each were identified on chronic shoulder problems. Further, one clinical trial each on 
TMJ pain,
100
 trigger point pain
101
 and myofascial pain;
102
 and one case study each on Herpes 
Zoster pain,
103
 heel neuroma,
104
 avascular necrosis of the femoral head,
105
 and multiple cases 
of pain
106
 were also identified. Two recently published clinical trials
39,107
 on carpal tunnel 
syndrome were also included. 
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Arthritis 
As identified, the highest number of studies on the effects of SWT was reported on arthritis, 
primarily OA of the knee joint. Hamilton and colleagues
51
 in their study published in 1959 
examined a heterogeneous mix of 62 patients suffering from either rheumatoid arthritis (RA; 
hands or knees) or OA knee. They reported that CSWT (12 sessions in 4 weeks, 20 minutes 
per session) improved outcomes of walking and stair climbing among the participants, but not 
significantly greater than other EPAs, or a placebo-CSWT. 
An experimental study by Harris
52
 suggested that CSWT exposure (single session for 20 
minutes) can improve circulation to the knee joints of people suffering from RA if the 
condition is quiescent whereas it can be counterproductive if the RA is active. In a later 
study, Wright
53
 gained better long-term improvement with CSWT (18 sessions in 6 weeks, 20 
minutes per session) over placebo tablets and placebo injections among 38 patients with OA 
knee when treated in three different groups. Several studies followed till the early 1990’s, 
where neither CSWT nor PSWT were found to be significantly better than any of the 
compared treatment methods.
54-61
 However, similar to the studies discussed above, none of 
these earlier trials employed a sufficiently robust methodology. Lack of adequate statistical 
power and absence of a true control group or long-term follow-ups were common to most of 
these studies. Nearly all the studies failed to report the SWT dosage parameters adequately 
(Table II). 
More recently, Klaber Moffett and colleagues
62
 agreed with the findings of the previous 
studies, as they found no significant differences between the active, control or placebo groups 
for self-reported pain and quality of life (QoL) measures of 92 subjects (nine sessions of 
PSWT in three weeks, 15 minutes per session). This was a well-designed RCT on patients 
suffering from hip and knee OA. Likewise, two very similar (small) clinical trials
64,65
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published in the last decade, which employed four different doses of PSWT (six and nine 
sessions respectively in two weeks, 20 minutes per session) between them in addition to a 
placebo dose, reported that there were no significant differences between any of the groups 
after the intervention. 
In contrast, PSWT (10 sessions in two weeks, 15 minutes per session) was shown to improve 
pain and function at both low and high doses when combined with ultrasound therapy and 
progressive resistance exercises in the study by Tuzun and colleagues.
63
 However, both the 
groups (20 participants each) had a battery of interventions. In another study by Jan and 
colleagues,
66
 pain and synovial thickness (measured using ultrasonography) were lower in 
CSWT-treated groups (30 sessions in 8 weeks, 20 minutes per session) compared to a control 
group regardless of the NSAID consumption. The study had only limited sample (36 
participants in three groups) and did not employ a randomised design. Also, the control group 
participants had significantly less pain at baseline compared to the CSWT group. 
Further studies followed, comparing the effects of SWT to spa, ultrasound, ice or exercise 
therapies. All these studies reported SWT to be either less effective or no better than the 
comparison groups.
67-69,73
 Among these studies, only the trial conducted by 
Rattanachaiyanont and Kuptniratsaikul
73
 employed a well-designed methodology with 
adequate statistical power. However, even that study employed only female participants and 
the mean PSWT power dosage used was only 3.2 W, which might be too low for a chronic 
condition such as OA. 
Among the recent studies, Cetin and colleagues
70
 suggested that CSWT (24 sessions in 8 
weeks, 15 minutes per session) when used with isokinetic exercises reduces pain and 
augments function among women with OA knee. These findings were contradicted by Akyol 
and colleagues,
74
 who stated that the addition of CSWT (12 sessions in four weeks, 20 
16 
 
minutes per session) to an isokinetic exercise programme brought no further significant 
benefits in terms of pain and functional QoL. Both studies were small and the results only 
applied to women of menopausal age group. Unlike these CSWT studies, PSWT delivered at 
a mean power (MP) of 14.5 W (9 sessions in 3 weeks, either 19 minutes or 38 minutes per 
session) produced significantly better results compared to a control group in the study by 
Ovanessian and colleagues.
72
  
Consistent with the above results, Fukuda and colleagues published two well-designed 
RCTs
71,75
 on the effects of PSWT on pain and function in women suffering from OA knee. 
Two doses of PSWT delivering either 17 KJ or 33 KJ of total energy (9 sessions in 3 weeks, 
19 or 38 minutes per session respectively) were tested against a placebo group and a control 
group. Both studies suggested that PSWT produced significantly better clinical outcomes 
over placebo and control. However, there was no significant difference between the effects 
produced by the two experimental doses. 
In another well-designed multi-centre RCT published recently by Atamaz and colleagues,
76
 
PSWT (15 sessions in three weeks, 20 minutes per session) was reported to have significantly 
improved the pain outcomes over a placebo resulting in lower consumption of NSAIDs. The 
study also had TENS and IFT treated groups, both of which produced similar results over the 
placebo. There were no significant differences between the three treatment modalities. 
However, it is not known whether these effects were sustained, as there were no follow-up 
assessments. Interestingly, similar to the Rattanachaiyanont and Kuptniratsaikul
73
 study, the 
mean PSWT power dose employed was only 3.2 W, which might be too low for a chronic 
condition such as OA. 
Among the two most recent studies identified, Boyaci and colleagues
78
 compared the effects 
of CSWT (10 sessions in two weeks, 20 minutes per session) with those of ultrasound and 
17 
 
ketoprofen phonophoresis among 101 women (in three groups) with OA knee. It was reported 
that all three groups improved significantly in terms of self-reported pain and function, with 
no significant differences between the groups. In the second smaller pilot study by Teslim 
and colleagues,
77
 CSWT (eight sessions in four weeks, 20 minutes per session) was reported 
to be more effective in improving the knee ROM and pain compared to PSWT (eight sessions 
in four weeks, 20 minutes per session) among 24 participants with OA knee (two groups of 
12 each). There were no follow-up assessments in either study and neither did they feature 
control or placebo groups. 
Although several of the earlier arthritis studies discussed above lacked robust methodological 
quality and gave conflicting results, many of the more recently published studies have 
supported the use of SWT (mainly PSWT) in the management of OA knee. Where reported, 
the dosage parameters and the overall duration of intervention varied greatly among the 
studies and the rationale for dose selection was not stated. The durations of intervention 
varied between single sessions to several weeks in most studies, with an average of 3–6 
weeks. No CSWT studies have reported their actual doses employed, apart from merely 
stating the (subjective) thermal levels of treatment. 
For OA knee, based on the evidence a mean PSWT power dose at or above 14.5 W, 8–12 
sessions over 4–6 weeks, and 15–20 minutes per session may be necessary for the treatment 
to be beneficial. 
Some of the studies considered here were also covered by systematic reviews published 
previously. The reader is advised to refer to those reviews
22,23,108,109
 for additional 
information. 
**Insert Table II here** 
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Low back pain 
Among the nine studies on chronic LBP, two large multi-group trials by Gibson and 
colleagues
81
 (12 CSWT sessions in four weeks, session duration not reported) and Sweetman 
and colleagues
83
 (six CSWT sessions in two weeks, 20 minutes per session) reported that 
CSWT has not been particularly beneficial over exercises, traction, osteopathy or placebo-
CSWT. Conversely, two other small clinical trials by Davies and colleagues
80
 (CSWT dose 
parameters not reported) and Wagstaff and colleagues
84
 (six PSWT sessions in three weeks, 
15 minutes per session) recommended that the effects of both pulsed and continuous SWT 
were significant in relation to pain relief. The latter also suggested that adding an exercise 
regime to the intervention, or using dissimilar shortwave pulse patterns did not change the 
outcome. 
Among the later studies, Kerem and Yigiter
82
 studied 60 subjects (three groups of 20 
participants each) and recommended that both CSWT and PSWT (10 sessions of 20 minutes 
each) effectively reduced LBP although the effects of PSWT were superior. Similarly, three 
studies published by the same research group (Shakoor and colleagues)
41,79,86
 reported that 
CSWT (18 sessions in 6 weeks, 15 minutes per session) significantly improved the efficacy 
of management of chronic LBP. In another recent study by Kim and colleagues,
85
 CSWT 
(single session of treatment, duration not reported) was found to significantly complement 
manual therapy (nerve mobilisation) in a group of 11 patients with LBP, compared to a 
similar group treated by manual therapy alone. 
The cohort of studies examining the effects of SWT on LBP was much smaller when 
compared to that of OA knee. The majority of studies employed CSWT and generally 
favoured its use for the management of LBP. The overall methodological quality of the 
studies remained low. Grouping issues, lack of follow-up assessments and poor baseline 
19 
 
equivalence between the study groups were apparent. Similar to the studies on several other 
conditions discussed here, the dosage parameters were not fully reported and they remained 
varied where reported. The rationale for dose selection was not stated, which combined with 
the lack of dose specific information made it impossible to draw any dose related 
conclusions. The duration of intervention ranged between single sessions to six weeks in 
most studies, with an average duration of 3–5 weeks. 
Pelvic pain 
Studies on pelvic conditions were published as early as 1938, when Waters
92
 reported 
positive responses to CSWT (up to 36 sessions delivered) from 120 gynaecological patients. 
Subsequently, Burgess
89
 reported a study of 50 cases of pelvic sepsis treated by CSWT (12–
16 sessions in 4–6 weeks, 30 minutes per session) to obtain intra-vaginal hyperthermia. 
Patients with gross chronic inflammation appeared to respond satisfactorily to the RF 
treatment. Later studies included a 71-patient case series of gynaecology patients by 
Punnonen and colleagues
91
 (10–15 PSWT sessions on alternate days) and two small case 
studies by Balogun and Okonofua
88
 (9 CSWT sessions in 3–4 weeks, 25–60 minutes per 
session) and Lamina and Hanif
90
 (15 CSWT sessions in 30 days, 30 minutes per session). All 
these studies suggested that SWT may be an effective treatment modality for pelvic pain 
arising from gynaecological conditions. 
Only one among the six identified studies in this category was an RCT,
87
 where Lamina and 
colleagues examined 32 subjects (in three groups) suffering from pelvic inflammatory disease 
and suggested that CSWT (15 sessions in 30 days, 20 minutes per session) showed significant 
benefit over analgesics and a placebo in reducing pain. This study was low in statistical 
power and lacked follow-up assessment. 
20 
 
On the whole, with only one RCT identified there is insufficient robust evidence to support 
the use of SWT for managing chronic pelvic pain secondary to gynaecological disorders. 
Neck pain 
Three studies (well-designed RCTs) were identified, which studied the effects of PSWT on 
chronic neck pain. Among them, two studies were based on the same data.
93,95
 In the first of 
the three studies, Foley-Nolan and colleagues
94
 demonstrated that PSWT therapy gave better 
outcomes of pain and neck ROM compared to a placebo. The active group participants wore 
a PSWT generating soft cervical collar eight hours daily for six weeks. This was a small 
study with 20 participants (divided in two groups), and without any long-term follow-up 
assessments. 
In a more recent and much larger pragmatic RCT, Dziedzic and colleagues
93
 studied 350 
patients in three groups (manual therapy, PSWT and control) over 32 weeks (8 PSWT 
sessions in 6 weeks, 15–20 minutes per session). The study suggested that the addition of 
either manual therapy or PSWT to ‘advice and exercise’ did not improve the outcomes. 
However, being a pragmatic trial, a potential drawback of this study was that it involved 55 
different therapists to deliver the intervention, potentially giving rise to reliability issues. 
Also, the treatment dosage was not fixed across the population, the decision being left to the 
treating clinician. In a later publication, Lewis and colleagues
95
 evaluated the economic 
outcomes of this study and concluded that the cost-effective intervention was likely to be 
advice and exercise or manual therapy depending on the economic perspective and preferred 
outcome, but not PSWT. 
Similar to the conditions on pelvic pain, there is insufficient evidence for the use of SWT in 
the management of chronic neck pain. Although the reported studies were of good 
methodological quality, no further studies have been identified. 
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Other conditions with pain and inflammation 
Two recent studies were identified on the use of portable PSWT devices in the management 
of plantar fasciitis.
96,97
 Brook and colleagues
96
 studied 70 patients placed in two groups (42 
active, 28 placebo) and demonstrated a significant reduction of morning pain in the actively-
treated group who wore a PSWT device during the night for seven days. However, the study 
lacked sufficient statistical power and did not perform any follow-up assessments. Similar 
results were also achieved by Michel in a brief case report with six participants.
97
 
Apart from plantar fasciitis, two studies were also identified on the use of SWT in chronic 
shoulder pain. In a case study published by Ginsberg,
99
 PSWT (10 minutes to the shoulder 
and 10 minutes to the liver) was shown to produce ‘impressive clinical results’ in the opinion 
of the author. The study involved 94 patients suffering from shoulder bursitis with 
calcification. In the second study, which was a more recent clinical trial,
98
 40 cases of 
shoulder adhesive capsulitis improved significantly with CSWT (10 sessions in 2 weeks, 20 
minutes per session), although it was found to be less effective compared to manual therapy 
(delivered according to the ‘Cyriax approach’). 
In two recently published studies,
39,107
 both CSWT and PSWT (15 sessions in 3 weeks, 20 
minutes per session) were reported to be effective in the management of mild and moderate 
carpal tunnel syndrome (CTS) compared to a placebo. Significant improvements were gained 
in pain, hand function and the electrophysiological measurements. In addition, CSWT was 
reported to be more effective in reducing symptom severity than either PSWT or placebo. 
Among other less reported conditions, Gray and colleagues
100
 published a clinical trial on 176 
patients with TMJ pain, comparing four active interventions (CSWT, PSWT, laser and 
ultrasound; 12 sessions in 4 weeks). The CSWT was applied for 10 minutes per session and 
PSWT 20 minutes per session. All groups reported significant improvement, but without any 
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significant difference between the groups. Myofascial pain (TMJ-related) was shown to 
improve markedly by CSWT in another trial with 120 patients
102
 (three groups: drug therapy, 
CSWT and ultrasound; 14 sessions of CSWT in 2 weeks, 20 minutes per session). 
Nonetheless, the effects of ultrasound therapy were superior to that of CSWT. In another 
brief study
101
 on the management of trigger point pain, a single session of CSWT (20 
minutes) was found to be more effective than a similar single session treatment with moist 
heat for reducing tenderness. The result, however, was not statistically significant. 
In case studies, SWT was found to be effective  in the management of pain associated with 
Herpes Zoster
103
 (daily CSWT sessions of 20 minutes each), heel neuroma
104
 (6–12 PSWT 
sessions in 3–4 weeks, 10–15 minutes per session), and avascular necrosis of the femoral 
head
105
 (PSWT for varying durations). No statistical reporting was done by any of these case 
studies. 
Overall, there is insufficient robust evidence to support the use of SWT in the management of 
any of the conditions discussed in this section. 
**Insert Table III here** 
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STUDIES ON TISSUE HEALING 
Out of the 16 studies identified in this category, 14 studies (88%) investigated the effects of 
RF on chronic wounds or chronic ulcers,
110-123
 and two on bone healing.
40,124
 As identified, 
all studies employed devices delivering RF energy in pulsed mode at the base shortwave 
frequency of 27.12 MHz (PSWT). Nine of these studies were case studies,
115-123
 one was a 
cohort study
110
 and a further four were clinical trials.
111-114
 The case studies reported the 
effectiveness of PSWT treatment of diabetic foot ulcers,
115,119,123
 chronic pressure 
ulcers,
116,122
 chronic lower extremity wounds,
117,120
 and venous/microvascular stasis 
ulcers.
118,121
 
In a cohort of 22 patients with pressure ulcers, Itoh and colleagues
110
 achieved faster healing 
when treated by PSWT (30 minutes twice daily) in addition to conventional treatment. Stage 
II ulcers, which remained unhealed after 3–12 weeks healed completely in 2.33 weeks on 
average and stage III ulcers unhealed after 8–168 weeks healed completely in 8.85 weeks on 
average. There was no control group in this study and any statistical analysis of the data was 
not reported. 
Among the clinical trials, Comorosan and colleagues
111
 treated 30 elderly patients with 
pressure ulcers in three separate groups, one of which received PSWT (30 minutes twice 
daily locally, 20 minutes once daily to the liver). The PSWT group showed much faster 
improvement (Stage II ulcers healed in 3.28 weeks and Stage III ulcers healed in 4.87 weeks 
on average) compared to the placebo and control groups that showed poor or no 
improvement. This trial had numerous methodological limitations including a low sample and 
absence of validated outcome measures and statistical analysis. 
In contrast, Salzberg and colleagues
112
 and Kloth and colleagues
114
 employed improved 
methods in their studies although the latter had a fairly small sample. In the first study, a 12-
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week PSWT treatment programme was found to significantly accelerate wound healing in 
spinal cord injured patients with stage II and stage III pressure ulcers.
112
 In the second study, 
four weeks of PSWT (20 sessions, 30 minutes per session) achieved significantly higher 
(64±15%) healing rate compared to a placebo (-8±24%).
114
 
In another small trial, 20 non-ambulatory male patients were treated for four weeks with four 
different PSWT pulse and field protocols (20 sessions, 20 minutes per session) in a well-
controlled double-blinded RCT by Seaborne and colleagues.
113
 The study had four groups, 
each acting as its own control. All groups improved significantly, but no significant 
difference existed between the groups. The study, however, was low on statistical power. 
Among the other studies, Sharp
124
 and Comorosan and colleagues
40
 reported accelerated bone 
repair with externally applied PSWT in 16 cases of non-union of fractures and 45 patients 
with post-traumatic algoneurodystrophies respectively. 
While the need for further quality research was evident, the existing studies indicated the 
potential usefulness of PSWT in facilitating the healing of pressure ulcers. The number of 
well-designed and adequately controlled studies on tissue healing was fairly low. The 
majority of studies did not report dosage parameters or the rationale for dose selection. Also, 
the durations of intervention varied greatly, making it difficult to draw any commonalities 
between the studies. 
**Insert Table IV here** 
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STUDIES ON OTHER APPLICATIONS 
While the majority of research centred on RF-based therapy for the reduction of pain and 
inflammation, and several others on tissue healing, a limited number of studies investigated 
conditions such as post-traumatic/post-surgical stiffness and ROM,
125-129
 and vascular 
disorders.
130,131
 
Results of some preliminary investigations on the therapeutic effect of PSWT on ‘intermittent 
claudication’ were published by Hedenius and colleagues in 1966.130 In a multi-group study, 
18 patients treated with PSWT (372 individual sessions in 62 weeks, 20 minutes per session) 
showed significantly improved skin temperature and walking tolerance over those who did 
not receive PSWT. Fair improvement in walking tolerance was also reported by Santoro and 
colleagues
131
 in a small cohort study of 10 participants suffering from peripheral vascular 
disease (PVD), when treated by CSWT (20 sessions in 4 weeks, 30 minutes per session). 
Five case studies
125-129
 published by Draper and colleagues demonstrated the clinical 
effectiveness of PSWT for improving ankle joint ROM
126
 (8–13 sessions in 5 weeks, 20 
minutes per session), elbow joint ROM
125,129
 (4–9 sessions in 2–3 weeks, 20 minutes per 
session) and symptoms of necrotising fasciitis
128
 (12–15 sessions in 6 weeks, 20 minutes per 
session to each body segment treated); and CSWT (daily sessions for 2 weeks, 20 minutes per 
session) for improving post-operative ROM in the knee joint.
127
 The RF treatment was 
combined with manual therapy and/or joint mobilisations in all cases. It is suggested that 
PSWT at thermal doses can be applied safely over areas with metal implants, if delivered 
with proper technique and caution.
125
 
High dose treatments using 38–48 W of energy were employed in all these case studies with 
the duration of intervention lasting 2–6 weeks. The dose selection was aimed at delivering 
heat to the tissues thereby raising the tissue temperature by up to 4
o
C. Nonetheless, proper 
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clinical trials with adequate control, sufficient sample and blinded methods need to be carried 
out before any conclusions can be drawn. 
**Insert Table V here** 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 
 
CONCLUSIONS 
Evidence favouring and against RF-based EPAs (between 30 kHz–30 MHz) as a treatment 
modality for chronic therapy-related clinical conditions is available. The majority of the 
identified studies (91%) were SWT-based, and done on conditions giving rise to pain and 
inflammation, mainly OA knee and chronic LBP. 
Although the review did not employ a cut-off score (Downs and Black) for the 
methodological quality, the conclusions drawn here are based primarily on the results 
reported by well-designed studies and the overall weightage of the available evidence. The 
authors could not determine a clear association between the quality scores achieved by the 
studies and their reported clinical outcome. While some studies that scored highly (>20) on 
the Downs and Black scale reported RF to be beneficial, some others reported them to be not 
beneficial. The same is true also for studies that scored low (<20) on the scale. 
Many of the studies published in the earlier decades gave conflicting results on the efficacy 
of SWT for the management of OA. However, several well-designed and recently published 
studies have supported the use of SWT in the treatment of OA; mainly in its pulsed form 
(PSWT). Hence, on the whole there is moderate evidence to support the use of PSWT in OA 
knee. Apart from OA knee, some evidence also exists favouring the use of CSWT to treat 
chronic LBP. Sufficient robust evidence does not exist for any other chronic conditions 
giving rise to pain and inflammation. 
For OA knee, based on the available evidence the authors recommend that a mean PSWT 
power dose at or above 14.5 W, 8–12 sessions over 4–6 weeks, and 15–20 minutes per 
session may be necessary for the treatment to be beneficial. No recommendations on CSWT 
dosing can be given for the treatment of LBP based on the available evidence, as the doses 
were not objectively reported adequately. 
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Some evidence also exists favouring the use of PSWT to promote the healing of chronic 
wounds, although the majority of studies identified in this category were case studies. While 
the need for more quality research was evident, the existing studies indicated the usefulness 
of PSWT in facilitating the healing of pressure ulcers. Although low in number, all reported 
clinical trials in this category were reasonably well-designed and favoured the use of PSWT 
for treating pressure ulcers. However, similar to LBP no recommendations on dosing can be 
given since the dosage parameters were rarely reported and the durations of intervention 
varied greatly among the studies. 
Since the bulk of the literature centred on applications pertaining to the reduction of pain and 
inflammation and several others to tissue healing, only a limited number of studies 
investigated the effects of RF-based therapy on other conditions such as tissue extensibility 
and ROM. All the identified studies in this area were case studies, and all of them indicated 
that PSWT may be potentially beneficial for improving ROM in the management of 
conditions such as post-traumatic stiffness. Nonetheless, proper clinical trials with adequate 
control, sufficient sample and blinded methods need to be carried out before any 
recommendations can be made. 
Only a limited number of clinical studies have been published in the non-shortwave RF 
frequency range on chronic conditions. Purely on the basis of the results reported, 448 kHz 
RF might be beneficial in delivering useful therapeutic effects. However, the paucity of 
clinical studies and their poor methodological quality suggest there is a need for more 
research in this area before such therapy can be recommended. 
The evidence reported in this review may only be considered against the overall quality of the 
studies, which was generally lacking. This is somewhat similar to the findings of part I
19
 of 
this review. Lack of robustness and integrity in the methodological designs and poor overall 
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reporting (including the reporting of dosage parameters) made the assessment of results 
problematic for most studies. Where doses were reported, the rationale for selection was 
unclear. Many trials also had flaws in their study grouping and did not demonstrate sufficient 
statistical equivalence between the groups at baseline, where comparisons were made 
between groups. Several studies either did not have adequate statistical power or failed to 
report any information relating to statistical power. Furthermore, participant drop-outs were 
sometimes high, but were not accounted for in the final analysis (no intention-to-treat 
analysis) as would be expected in a more recent publication. The lack of consistency in 
reporting and poor methodological quality was particularly evident in the earlier studies. 
Although both criteria were increasingly met in the more recent studies, proper reporting of 
the dosage parameters continued to be an issue. 
Despite the fact that RF-based EPAs have been used in therapy practice for almost a century, 
research in this area remains limited. Both the number of studies published on their effects on 
chronic conditions, and the types of conditions researched are limited. This warrants 
substantially more research in this area. Nonetheless, the overall numbers are greater than 
that was identified on the acute conditions in part I.
19
 A lack of research emphasis is 
particularly evident on the non-shortwave RF band, where only a very small number of 
studies were identified. This warrants particular emphasis in this area especially since EPAs 
delivering non-shortwave RF are already in clinical use and that the studies published so far 
have reported encouraging results. 
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Figure 1: Flow of studies through the review. 
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Figure 2: Clinical areas and study types. 
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Table 1: Studies in the non-shortwave frequency range. 
Study 
Diagnostic 
category 
Outcomes 
measured 
Study type, sample 
size and number of 
groups  
Type of 
RF used 
RF dose parameters 
Number and 
duration of sessions 
Did RF 
improve the 
outcomes 
significantly? 
Downs and 
Black score 
(out of 28) 
CRF 
Power 
(W) 
PRF 
PP 
(W) 
PD  
(µs) 
PRR 
(pps) 
MP 
(W) 
Al-Badawi et al.
42 TMJ pain and 
dysfunction 
Pain and 
TMJ function 
RCT; 40 subjects; 
2 groups 
PRF; 
0.25 MHz 
 NR NR 600 NR 
6 (over 2 weeks); 
90 sec/session 
Yes 21 
Costantino et al.
43 
Tendinopathy Pain 
Non-RCT; 
45 subjects; 
3 groups 
CRF; 
0.48 MHz 
NR     
12 (NR); 
30 min/session 
Yes 15 
Alcidi et al.
44 
OA knee 
Pain and 
function 
RCT; 42 subjects; 
2 groups 
CRF; 
0.5 MHz 
≤30     
5 (over 5 days); 
20 min/session 
Yes 17 
Taverner et al.
45 
OA knee Pain 
RCT; 52 subjects; 
2 groups 
PRF; 
0.48 MHz 
 NR 20,000 2 NR 
Single session; 
10 min/session 
Yes 20 
Nelson et al.
46 
OA knee Pain 
RCT; 34 subjects; 
2 groups 
PRF; 
6.8 MHz 
 NR 7000 1 NR 
≤89 (over 42 days); 
15 min/session 
Yes 25 
Takahashi et al.
47
 OA knee 
Pain and 
function 
Cohort; 11 subjects 
(12 knees); 1 group 
PRF; 
8 MHz 
 NR NR NR 200 
3 (over 3 weeks); 
20 min/session 
Yes 16 
Balogh
48
 
Back pain, 
Multiple injuries 
Pain 
Case series; 
4 subjects 
PRF; 
0.5 MHz 
 NR 20,000 2 NR 
Numerous; 
10 min/session 
Yes 9 
Taverner et al.
49 
Shoulder pain Pain 
Retrospective 
audit; 13 subjects 
(15 shoulders) 
PRF; 
0.48 MHz 
 NR 
20,000/
10,000 
2/5 NR 
Single session; 
≤12 min/session 
Yes 9 
 
RCT – Randomised Controlled Trial; OA – Osteoarthritis; TMJ – Temporo-mandibular Joint; RF – Radiofrequency; CRF – Continuous Radiofrequency; PRF – Pulsed Radiofrequency; PP – Peak 
power; PD – Pulse duration; PRR – Pulse repetition rate; MP – Mean power; NR – Not reported; NA – Not available to the authors; W – Watts; µs – Microseconds; pps – Pulses per second; 
min – Minutes. 
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Table 2: Studies on pain and inflammation (arthritis). 
Study 
Diagnostic 
category 
Outcomes measured 
Study type, 
sample size and 
number of groups  
Type of 
RF used 
RF dose parameters 
Number and 
duration of sessions 
Did RF 
improve the 
outcomes 
significantly? 
Downs and 
Black score 
(out of 28) 
CSWT 
Power 
(W) 
PSWT 
PP 
(W) 
PD  
(µs) 
PRR 
(pps) 
MP 
(W) 
Hamilton et al.
51
 
RA hands/ 
knee; 
OA knee 
ROM and function 
Crossover RCT; 
131 subjects; 
4 groups 
CSWT NR     
12 (over 4 weeks); 
20 min/session 
Yes 16 
Harris
52
 RA knee 
Local circulation 
(Radio-Sodium 
clearance) 
Experimental; 
16 subjects; 
2 groups 
CSWT NR     
Single session; 
20 min/session 
Yes/No 8 
Wright
53
 OA knee 
Pain, tenderness, 
walking time and 
analgesic intake 
RCT; 38 subjects 
(59 joints); 
3 groups 
CSWT NR     
18 (over 6 weeks); 
20 min/session 
Yes 13 
Valtonen and 
Alaranta
54
 
OA 
knee/hip 
Level of 
improvement 
RCT; 160 subjects; 
2 groups 
CSWT NR     
13–14  (over 5 
weeks); 
15–20 min/session 
Yes 10 
Clarke et al.
55
 OA knee 
Pain, stiffness, 
tenderness and 
swelling 
RCT; 48 subjects; 
3 groups 
CSWT NR     
9 (over 3 weeks); 
NR 
No 18 
Bansil and Joshi
56
 OA knee Pain and function 
RCT; 60 subjects 
(100 joints); 
2 groups 
CSWT NR     NR; 20 min/session No 12 
Chamberlain et 
al.
57
 
OA knee 
Pain, function, ROM, 
maximum weight lift 
and endurance 
RCT; 42 subjects; 
2 groups 
CSWT NR     
12 (over 4 weeks; 
NR 
Yes 17 
Quirk et al.
58
 OA knee 
Pain, function, ROM, 
exercise endurance 
and knee girth 
RCT; 38 subjects; 
3 groups 
CSWT NR     
12 (over 4 weeks); 
20 min/session 
Yes 17 
Svarcova et al.
59
 
OA 
knee/hip 
Pain and ‘therapeutic 
effect’ 
Non-RCT; 
180 subjects; 
3 groups 
PSWT  700 NR NR NR 
10 (over 3 weeks); 
4 min/session 
Yes 15 
41 
 
Jan and Lai
60
 OA knee 
Function and muscle 
torque 
RCT; 61 subjects 
(94 joints); 
4 groups 
CSWT NR     
24–69 (over 6–18 
weeks); 
20 min/session 
Yes 15 
Sewell et al.
61
 
(Abstract only) 
RA knee 
Pain, swelling and 
function 
RCT; 81 subjects; 
2 groups 
PSWT  NR 65 
200 
(1:3) 
NR 
8 (over 4 weeks); 
10 min/session 
No NA 
Klaber Moffett 
et al.
62
 
OA 
knee/hip 
Pain and function 
RCT; 92 subjects; 
3 groups 
PSWT  NR NR 82 23 
9 (over 3 weeks); 
15 min/session 
No 19 
Tuzun et al.
63
 OA knee 
Pain, function, ROM 
and muscle strength 
RCT; 40 subjects; 
2 groups 
PSWT  
1000/
600 
400 
20/ 
110 
8/ 
26.4 
10 (over 2 weeks); 
15 min/session 
Yes 15 
Callaghan et al.
64
 OA knee 
Pain, timed walk, 
ROM and muscle 
strength 
RCT; 27 subjects; 
3 groups 
PSWT  125 
200/ 
400 
400 10/20 
6 (over 2 weeks); 
20 min/session 
No 22 
Laufer et al.
65
 OA knee 
Pain, function, timed 
walk and stair use 
Non-RCT; 
103 subjects; 
3 groups 
PSWT  200 
82/ 
300 
110/ 
300 
1.8/ 
18 
9 (over 3 weeks); 
20 min/session 
No 19 
Jan et al.
66
 OA knee 
Pain and synovial sac 
thickness 
Non-RCT; 
30 subjects 
(44 joints); 
3 groups 
CSWT NR     
30 (over ≤8 weeks); 
20 min/session 
Yes 17 
Cantarini et al.
67
 OA knee 
Pain, function, QoL 
and analgesic intake 
RCT; 74 subjects; 
3 groups 
CSWT NR     
10 (over 3 weeks); 
15 min/session 
No 20 
Manhal et al.
68
 OA knee 
Pain, deformity and 
muscle wasting 
RCT; 24 subjects; 
2 groups 
CSWT NR     
6–10 (over 2 
weeks); 
≤20 min/session 
Yes 8 
Silva et al.
69
 OA knee 
Pain, function, ROM 
and muscle strength 
RCT; 25 subjects; 
3 groups 
CSWT NR     
10 (over 5 weeks); 
20 min/session 
No 16 
Cetin et al.
70
 OA knee 
Pain, function and 
muscle strength 
RCT; 100 subjects 
(200 joints); 
5 groups 
CSWT NR     
24 (over 8 weeks); 
15 min/session 
Yes 20 
Fukuda et al.
71
 OA knee 
Pain, function and 
ROM 
RCT; 84 subjects; 
4 groups 
PSWT  250 400 145 14.5 
9 (over 3 weeks); 
19–38 min/session 
Yes 21 
Ovanessian et 
al.
72
 
OA knee 
Pain, function and 
ROM 
RCT; 42 subjects; 
3 groups 
PSWT  250 400 145 14.5 
9 (over 3 weeks); 
19–38 min/session 
Yes 17 
42 
 
Rattanachaiyanon
-t and 
Kuptniratsaikul
73
 
OA knee 
Pain, function, timed 
walk and stair use 
RCT; 113 subjects; 
2 groups 
PSWT  300 NR NR 3.2 
9 (over 3 weeks); 
20 min/session 
No 24 
Akyol et al.
74
 OA knee 
Pain, function, QoL 
and timed walk 
RCT; 40 subjects 
(80 joints); 
2 groups 
CSWT NR     
12 (over 4 weeks); 
20 min/session 
No 21 
Fukuda et al.
75
 OA knee 
Pain, function and 
QoL 
RCT; 121 subjects; 
4 groups 
PSWT  250 400 145 14.5 
9 (over 3 weeks); 
19–38 min/session 
Yes 25 
Atamaz et al.
76
 OA knee 
Pain, function and 
ROM 
RCT; 203 subjects; 
6 groups 
PSWT  300 NR NR 3.2 
15 (over 3 weeks); 
20 min/session 
Yes 26 
Teslim et al.
77
 OA knee Pain and ROM 
RCT; 24 subjects; 
2 groups 
CSWT/ 
PSWT 
NR NR NR NR NR 
8 (over 4 weeks); 
20 min/session 
Yes 17 
Boyaci et al.
78
 OA knee 
Pain, function and 
timed walk 
RCT; 101 subjects 
(202 joints); 
3 groups 
CSWT NR     
10 (over 2 weeks); 
20 min/session 
Yes 23 
 
RCT – Randomised Controlled Trial; OA – Osteoarthritis; RA – Rheumatoid Arthritis; ROM – Range of Movement; QoL – Quality of Life; RF – Radiofrequency; CSWT – Continuous Shortwave 
Therapy; PSWT – Pulsed Shortwave Therapy; PP – Peak power; PD – Pulse duration; PRR – Pulse repetition rate; MP – Mean power; NR – Not reported; NA – Not available to the authors; W 
– Watts; µs – Microseconds; pps – Pulses per second; min – Minutes. 
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Table 3: Studies on pain and inflammation (All others excluding arthritis). 
Study 
Diagnostic 
category 
Outcomes 
measured 
Study type, 
sample size and 
number of groups 
Type 
of RF 
used 
RF dose parameters 
Number and 
duration of sessions 
Did RF 
improve the 
outcomes 
significantly? 
Downs and 
Black score 
(out of 28) 
CSWT 
Power 
(W) 
PSWT 
PP (W) 
PD  
(µs) 
PRR 
(pps) 
MP 
(W) 
Incebiyik et al.
39
 
Carpal tunnel 
syndrome 
Pain and function 
RCT; 31 subjects 
(58 joints); 
2 groups 
CSWT NA     
15 (over 3 weeks); 
NA 
Yes NA 
Shakoor et al.
41
 LBP Pain 
RCT; 102 subjects; 
2 groups 
CSWT NA     NA Yes NA 
Ahmed et al.
79
 LBP 
Pain, tenderness 
and analgesic 
intake 
RCT; 97 subjects; 
2 groups 
CSWT NR     
18 (over 6 weeks); 
15 min/session 
Yes 17 
Davies et al.
80
 LBP 
Pain and flexion 
ROM 
RCT; 43 subjects; 
3 groups 
CSWT NR     
NR (over 4 weeks); 
NR 
Yes 17 
Gibson et al.
81
 LBP 
Pain and flexion 
ROM 
RCT; 109 subjects; 
3 groups 
CSWT NR     
12 (over 6 weeks); 
NR 
No 18 
Kerem and 
Yigiter
82
 
LBP 
Pain, ROM and 
muscle strength 
Non-RCT (?); 
60 subjects; 
3 groups 
CSWT/ 
PSWT 
NR 
300/ 
600 
4000 
200/ 
46 
240/ 
110 
10 (NR); 
20 min/session 
Yes 17 
Sweetman et 
al.
83
 
LBP Clinical outcome 
RCT; 400 subjects; 
4 groups 
CSWT NR     
6 (over 2 weeks); 
20 min/session 
No 20 
Wagstaff et al.
84
 LBP Pain 
RCT; 23 subjects; 
3 groups 
CSWT/ 
PSWT 
NR 
300/ 
700 
400 
200/ 
82 
23.4/ 
23.2 
6 (over 3 weeks); 
15 min/session 
Yes 14 
Kim et al.
85
 LBP 
Pain, function and 
knee extensor 
strength 
RCT; 22 subjects; 
2 groups 
CSWT 50     
Single session; 
NR 
Yes 17 
Shakoor et al.
86
 LBP 
Pain and 
tenderness 
Cohort study; 
50 subjects; 
1 group 
CSWT NR     
18 (over 6 weeks); 
15 min/session 
Yes 14 
Lamina et al.
87
 PID 
Pain and 
inflammation 
RCT; 32 subjects; 
3 groups 
CSWT ≈8.27     
15 (over 4 weeks); 
20 min/session 
Yes 19 
44 
 
Balogun and 
Okonofua
88
 
PID Pain 
Case study; 
1 subject 
CSWT NR     
9 (over 3 weeks); 
25–60 min/session 
Yes 7 
Burgess
89
 
Mixed cases of 
pelvic sepsis 
Pain and 
treatment 
outcome 
Case series; 
50 subjects 
CSWT NR     
12–16 
(over ≤6 weeks); 
30 min/session 
Yes 4 
Lamina and 
Hanif
90
 
PID Pain 
Case series; 
3 subjects 
CSWT NR     
15 (over 4 weeks); 
30 min/session 
Yes 9 
Punnonen et 
al.
91
 
Mixed 
gynaecology and 
obstetrics cases 
Pain and 
treatment 
outcome 
Case series; 
71 subjects 
PSWT  300 NR 62 NR 
10–15 
(over 3–4 weeks); 
30 min/session 
Yes 6 
Waters
92
 
Mixed 
gynaecology and 
obstetrics cases 
Pain and 
treatment 
outcome 
Case series; 
120 subjects 
CSWT NR     
≤36 (over ≤4 
weeks); 
≈15 min/session 
Yes 6 
Dziedzic et al.
93
 
Non-specific neck 
pain 
Pain and function 
RCT; 350 subjects; 
3 groups 
PSWT  NR NR NR ≈7.4 
8 (over 6 weeks); 
20 min/session 
Yes 22 
Foley-Nolan et 
al.
94
 
Neck pain Pain and ROM 
RCT; 20 subjects; 
2 groups 
PSWT  NR 60 450 
0.001
5/cm
2
 
48 (over 6 weeks); 
8 hours/session 
Yes 19 
Lewis et al.
95
 
Non-specific neck 
pain 
Cost effectiveness 
RCT; 350 subjects; 
3 groups 
PSWT  NR NR NR ≈7.4 
8 (over 6 weeks); 
20 min/session 
Yes, 
but not cost 
effective 
22 
Brook et al.
96
 Plantar fasciitis Morning pain 
RCT; 70 subjects; 
2 groups 
PSWT  
98 x 
10
-4 100 1000 
98 x 
10
-5 
7 (over 1 week); 
NR 
Yes 24 
Michel
97
 Plantar fasciitis 
Pain and 
tenderness 
Case series; 
6 subjects 
PSWT  NR NR NR NR 
≤215 (over 13–15 
weeks); 
30 min/session 
Yes 7 
Guler-Uysal and 
Kozanoglu
98
 
Adhesive 
capsulitis 
shoulder 
Recovery rate, 
pain and ROM 
RCT; 40 subjects; 
2 groups 
CSWT NR     
10 (over 2 weeks); 
20 min/session 
Yes 20 
Ginsberg
99
 
Calcified bursitis 
shoulder 
Calcium 
absorption rate 
Case series; 
94  subjects 
PSWT  
1025/
NR 
65 
600/ 
400 
40/ 
NR 
NR; 
20 min/session 
Yes 7 
Gray et al.
100
 
TMJ pain and 
dysfunction  
Pain, ‘clinical 
signs’ and 
mandibular ROM 
RCT; 176 subjects; 
5 groups 
CSWT/
PSWT 
NR NR 60 100 NR 
12 (over 4 weeks); 
10/20 min/session 
Yes 15 
McCray and 
Patton
101
 
Trigger points Pain 
RCT; 19 subjects; 
2 groups 
PSWT  NR NR NR NR 
Single session; 
20 min/session 
Yes 14 
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Talaat et al.
102
 
Myofascial pain 
syndrome 
Pain, tenderness, 
TMJ noises and 
ROM 
RCT; 120 subjects; 
3 groups 
CSWT  NR NR NR NR 
14 (over 2 weeks); 
20 min/session 
Yes 10 
Allberry et al.
103
 
Herpes zoster 
pain 
Pain 
Case series; 
97 subjects 
CSWT  NR NR NR NR NR; 20 min/session Yes 7 
Shandles et 
al.
104
 
Heel neuroma Pain 
Case series; 
317 subjects 
PSWT  
975/ 
NR 
65 
600/ 
400 
38/ 
NR 
≈6–9 (over ≈3 
weeks); 
20–30 min/session 
Yes 4 
Oke et al.
105
 AVN femoral head Pain and ROM 
Case series; 
4 subjects 
PSWT  200 400 400 32 
≈72 (over 4 
months); 
20 min/session 
Yes 7 
Taylor
106
 
Abscess, 
neuralgia, neuritis 
Pain 
Case series; 
3 subjects 
CSWT  NR NR NR NR NR; NR Yes 4 
Boyaci et al.
107
 
Carpal tunnel 
syndrome 
Pain, function and 
nerve conduction  
RCT; 30 subjects 
(55 joints); 
3 groups 
CSWT/ 
PSWT 
NR NR 400 82 NR 
15 (over 3 weeks); 
20 min/session 
Yes 24 
 
RCT – Randomised Controlled Trial; LBP – Low Back Pain; PID – Pelvic Inflammatory Disease; AVN – Avascular Necrosis; TMJ – Temporo-mandibular Joint; ROM – Range of Movement; RF – 
Radiofrequency; CSWT – Continuous Shortwave Therapy; PSWT – Pulsed Shortwave Therapy; PP – Peak power; PD – Pulse duration; PRR – Pulse repetition rate; MP – Mean power; NR – Not 
reported; NA – Not available to the authors; W – Watts; µs – Microseconds; pps – Pulses per second; min – Minutes. 
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Table 4: Studies on tissue healing. 
Study 
Diagnostic 
category 
Outcomes 
measured 
Study type, sample 
size and number of 
groups 
Type 
of RF 
used 
RF dose parameters 
Number and duration of 
sessions 
Did RF 
improve the 
outcomes 
significantly? 
Downs and 
Black score 
(out of 28) 
CSWT 
Power 
(W) 
PSWT 
PP 
(W) 
PD  
(µs) 
PRR 
(pps) 
MP 
(W) 
Comorosan et 
al.
40
 
Post-
traumatic 
Algoneurodyst
-rophies 
NA 
Cohort; 
45 subjects 
PSWT  NA NA NA NA NA; NA Yes NA 
Itoh et al.
110
 
Pressure 
ulcers 
Ulcer size and 
healing rate 
Cohort; 20 subjects 
(22 ulcers); 1 group 
PSWT  975 65 600 38 
≤308 (over ≤22 weeks); 
30 min/session 
Yes 13 
Comorosan et 
al.
111
 
Pressure 
ulcers 
Ulcer size and 
healing rate 
RCT; 30 subjects; 
3 groups 
PSWT  
975/
NR 
65 
600/ 
400 
38/ 
NR 
≤112 (over ≤8 weeks); 
30/20 min/session 
Yes 15 
Salzberg et al.
112
 
Pressure 
ulcers 
Ulcer size and 
healing rate 
RCT; 30 subjects; 
2 groups 
PSWT  NR NR NR NR 
NR (over ≤12 weeks); 
NR 
Yes 20 
Seaborne et 
al.
113
 
Pressure 
ulcers 
Ulcer size 
RCT; 20 subjects; 
4 groups 
PSWT  700 400 
110/ 
20 
30.8/ 
5.6 
20 (over 2 weeks); 
20 min/session 
Yes 23 
Kloth et al.
114
 
Pressure 
ulcers 
Ulcer size 
RCT; 10 subjects; 
2 groups 
PSWT  NR 65 600 NR 
20 (over 4 weeks); 
30 min/session 
yes 20 
Larsen and 
Overstreet
115
 
Diabetic foot 
ulcers 
Ulcer size and 
healing rate 
Case series; 
2 subjects 
PSWT  NR 42 1000 NR 
NR (over 16–17 weeks); 
NR 
Yes 9 
Porreca and 
Giordano-
Jablon
116
 
Pressure 
ulcers 
Ulcer size 
Case study; 
1 subject 
PSWT  NR 42 1000 NR 
60–420 (1–7 months); 
30 min/session 
Yes 7 
Frykberg et 
al.
117
  
Pressure, 
diabetic and 
venous ulcers 
Ulcer size 
Case series; 
4 subjects 
PSWT  NR 42 1000 NR 
120–240 (over 2–4 
months); 
30 min/session 
Yes 9 
Fletcher
118
 Venous ulcer 
Pain and ulcer 
size 
Case study; 
1 subject 
PSWT  NR 42 1000 NR 
≈150 (over 6 weeks); 
30 min/session 
Yes 7 
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Frykberg et 
al.
119
 
Diabetic foot 
ulcers 
Ulcer size 
Case study; 
1 subject 
PSWT  NR 42 1000 NR 
≈200 (over 14 weeks); 
30 min/session 
Yes 7 
Frykberg et 
al.
120
 
Pressure, 
diabetic and 
venous ulcers 
Ulcer size 
Cohort (retrospective 
audit); 113 subjects; 
1 group 
PSWT  NR 42 1000 NR 
56 (over 4 weeks); 
30 min/session 
Yes 14 
Maier
121
 
Cutaneous 
ulcers of the 
ankle 
Ulcer size 
Case series; 
2 subjects 
PSWT  NR 42 1000 NR 
42–392 (over 3–28 
weeks); 
30 min/session 
Yes 8 
Conner-Kerr 
and Isenberg
122
 
Pressure 
ulcers 
Ulcer size and 
healing rate 
Cohort (retrospective 
audit); 89 subjects; 
1 group 
PSWT  NR 42 1000 NR 
56 (over 4 weeks); 
30 min/session 
Yes 14 
Rawe and 
Vlahovic
123
 
Diabetic foot 
ulcers and 
venous ulcer 
Ulcer size and 
pain 
Case series; 
4 subjects 
PSWT  NR NR 1000 NR 
21–42 (over 3–6 weeks); 
6–8 hours/session 
Yes 9 
Sharp and 
Lightwood
124
 
Fracture 
non/delayed 
union 
Healing rate 
Case series; 
16 subjects 
PSWT  NR NR NR NR 
NR (over 11–54 weeks); 
NR 
Yes 6 
 
RCT – Randomised Controlled Trial; RF – Radiofrequency; CSWT – Continuous Shortwave Therapy; PSWT – Pulsed Shortwave Therapy; PP – Peak power; PD – Pulse duration; PRR – Pulse 
repetition rate; MP – Mean power; NR – Not reported; NA – Not available to the authors; W – Watts; µs – Microseconds; pps – Pulses per second; min – Minutes. 
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Table 5: Studies on other less reported conditions. 
Study 
Diagnostic 
category 
Outcomes measured 
Study type, 
sample size 
and 
number of 
groups 
Type of 
RF used 
RF dose parameters 
Number and 
duration of 
sessions 
Did RF 
improve the 
outcomes 
significantly? 
Downs and 
Black score 
(out of 28) 
CSWT 
Power 
(W) 
PSWT 
PP 
(W) 
PD  
(µs) 
PRR 
(pps) 
MP 
(W) 
Draper et 
al.
125
 
Post-traumatic 
(fracture) 
stiffness (elbow) 
ROM 
Case study; 
1 subject 
PSWT  150 400 800 48 
6 (over 2 weeks); 
20 min/session 
Yes 11 
Seiger and 
Draper
126
 
Post-traumatic 
(fracture) 
stiffness (ankle) 
ROM 
Case series; 
4 subjects 
PSWT  150 400 800 48 
8–13 (over 3–5 
weeks); 
20 min/session 
Yes 12 
Draper and 
VanPatten
127
 
Post-surgical 
stiffness (knee) 
ROM 
Case study; 
1 subject 
CSWT 35     
6 (over 2 weeks); 
20 min/session 
Yes 11 
Johnson and 
Draper
128
 
Fibrosis and 
adhesions post 
breast cancer 
ROM 
Case study; 
1 subject 
PSWT  150 400 800 48 
12–15 (over 6 
weeks); 
20 min/session 
Yes 11 
Draper
129
 
Post-traumatic/ 
Post-surgical 
stiffness (elbow) 
ROM 
Case series; 
6 subjects 
PSWT  150 400 800 48 
4–6 (over 2 
weeks); 
20 min/session 
Yes 12 
Hedenius et 
al.
130
 
Intermittent 
claudication 
Toe skin temperature, 
walking tolerance, 
oscillography and calf 
circumference 
Non-RCT; 
58 subjects; 
5 groups 
PSWT  975 65 600 38 
372 (over 62 
weeks); 
20 min/session 
Yes 14 
Santoro et 
al.
131
 
Arterial 
peripheral 
vascular disease 
Doppler pressure, Laser 
Doppler Flowmetry, 
transcutaneous partial 
pressure of oxygen and 
thermistor thermography 
Cohort; 
10 subjects; 
1 group 
PSWT  NR 95 
7000/ 
700 
NR 
20 (over 4 weeks); 
30 (20+10) 
min/session 
Yes 12 
 
RCT – Randomised Controlled Trial; ROM – Range of Movement; RF – Radiofrequency; CSWT – Continuous Shortwave Therapy; PSWT – Pulsed Shortwave Therapy; PP – Peak power; PD – 
Pulse duration; PRR – Pulse repetition rate; MP – Mean power; NR – Not reported; NA – Not available to the authors; W – Watts; µs – Microseconds; pps – Pulses per second; min – Minutes. 
